We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$170M
AUM Growth
+$1.92M
Cap. Flow
+$1.49M
Cap. Flow %
0.88%
Top 10 Hldgs %
41.96%
Holding
117
New
6
Increased
39
Reduced
48
Closed
7

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$765K
2
AMD icon
Advanced Micro Devices
AMD
+$615K
3
GEV icon
GE Vernova
GEV
+$615K
4
DIS icon
Walt Disney
DIS
+$589K
5
ABBV icon
AbbVie
ABBV
+$504K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$506K
2
TSM icon
TSMC
TSM
+$339K
3
ALB icon
Albemarle
ALB
+$337K
4
JPM icon
JPMorgan Chase
JPM
+$310K
5
NVO
Novo Nordisk
NVO
+$298K

Sector Composition

Rank Sector Weight
1 Technology 38.64%
2 Consumer Staples 11.55%
3 Healthcare 11.29%
4 Consumer Discretionary 9.05%
5 Financials 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$191B
$1.92M 1.13%
12,605
-493
-4% -$80.8K
XOM icon
27
ExxonMobil
XOM
$645B
$1.87M 1.1%
17,419
+48
+0.3% +$5.62K
PM icon
28
Philip Morris
PM
$298B
$1.79M 1.06%
14,909
-424
-3% -$53.5K
SJM icon
29
J.M. Smucker
SJM
$12.8B
$1.6M 0.94%
14,572
-1,561
-10% -$180K
NFLX icon
30
Netflix
NFLX
$299B
$1.6M 0.94%
17,920
+540
+3% +$44.4K
JNJ icon
31
Johnson & Johnson
JNJ
$618B
$1.57M 0.92%
10,825
-940
-8% -$146K
CCJ icon
32
Cameco
CCJ
$37.5B
$1.53M 0.9%
29,734
+5,518
+23% +$301K
AMD icon
33
Advanced Micro Devices
AMD
$778B
$1.48M 0.87%
12,290
+4,277
+53% +$615K
IBM icon
34
IBM
IBM
$211B
$1.48M 0.87%
6,741
+158
+2% +$35.2K
UNP icon
35
Union Pacific
UNP
$173B
$1.46M 0.86%
6,420
+68
+1% +$16.1K
ADBE icon
36
Adobe
ADBE
$99.6B
$1.44M 0.84%
3,228
-300
-9% -$149K
REGN icon
37
Regeneron Pharmaceuticals
REGN
$78.6B
$1.4M 0.82%
1,964
+125
+7% +$105K
NOW icon
38
ServiceNow
NOW
$115B
$1.37M 0.81%
6,465
+225
+4% +$45.6K
GE icon
39
GE Aerospace
GE
$375B
$1.37M 0.8%
8,204
+4,290
+110% +$765K
NVO
40
Novo Nordisk
NVO
$208B
$1.35M 0.8%
15,724
-2,760
-15% -$298K
MRK icon
41
Merck
MRK
$322B
$1.24M 0.73%
12,421
+1,235
+11% +$127K
GLD icon
42
SPDR Gold Trust
GLD
$131B
$1.22M 0.72%
5,031
-525
-9% -$129K
GNRC icon
43
Generac Holdings
GNRC
$11.6B
$1.17M 0.69%
7,527
+645
+9% +$111K
ABBV icon
44
AbbVie
ABBV
$444B
$1.11M 0.65%
6,249
+2,739
+78% +$504K
PSX icon
45
Phillips 66
PSX
$84.8B
$1.06M 0.63%
9,334
+370
+4% +$47.1K
IWM icon
46
iShares Russell 2000 ETF
IWM
$79.8B
$1.06M 0.62%
4,790
+1,580
+49% +$360K
ILMN icon
47
Illumina
ILMN
$31B
$1.05M 0.62%
7,839
-198
-2% -$28.2K
WRB icon
48
W.R. Berkley
WRB
$26.9B
$1.03M 0.6%
17,549
-100
-0.6% -$5.99K
CMG icon
49
Chipotle Mexican Grill
CMG
$47.3B
$985K 0.58%
16,340
+3,850
+31% +$232K
PANW icon
50
Palo Alto Networks
PANW
$271B
$980K 0.58%
5,384
-590
-10% -$111K

Similar funds

Fairfield, Bush & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Fairfield, Bush & Co held 117 positions worth $170M, up 1.1% from $168M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fairfield, Bush & Co's Q4 2024 filing shows 6 new, 39 increased, 48 reduced and 7 closed positions. Its largest new stake was GE Vernova: 1,968 shares worth $647K. The largest sale was Thermo Fisher Scientific, an estimated $506K.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 37% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Fairfield, Bush & Co's largest Q4 2024 buy was GE Vernova: 1,968 shares worth $647K.
  • Fairfield, Bush & Co added most to GE Aerospace in Q4 2024, an estimated $765K increase.
  • Fairfield, Bush & Co's biggest Q4 2024 reduction was Thermo Fisher Scientific, cutting an estimated $506K.
  • Fairfield, Bush & Co fully exited Albemarle in Q4 2024, selling an estimated $337K.
  • Fairfield, Bush & Co's ten largest holdings make up 42% of its $170M portfolio in Q4 2024.
  • Fairfield, Bush & Co opened 6 new positions and closed 7 in Q4 2024.
  • Fairfield, Bush & Co's portfolio value rose 1.1% quarter-over-quarter to $170M.

Based on Fairfield, Bush & Co's 13F filing for Q4 2024, filed 13 Feb 2025.